ACM
KPRX icon

AIGH Capital Management’s Kiora Pharmaceuticals KPRX Stock Holding History

AIGH Capital Management’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-216,345
Closed -$623K – 48
2025
Q2 		$623K Sell
216,345
-37,210
-15% -$113K 0.28% 32
2025
Q1 		$763K Sell
253,555
-2,000
-0.8% -$6.95K 0.32% 38
2024
Q4 		$850K Hold
255,555
– – 0.27% 32
2024
Q3 		$935K Sell
255,555
-6
-0% -$23 0.26% 32
2024
Q2 		$1.07M Buy
255,561
+5
+0% +$23 0.33% 30
2024
Q1 		$1.62M Buy
+255,556
New +$1.43M 0.49% 34

Other funds holding KPRX

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

AIGH Capital Management's KPRX Position: Q3 2025 in Review

AIGH Capital Management sold out of Kiora Pharmaceuticals (KPRX) in Q3 2025, closing a stake of 216,345 shares — an estimated $623K sold.

AIGH Capital Management first reported a position in KPRX in Q1 2024 and held it in 6 quarters. The position peaked at $1.62M in Q1 2024. 17 funds tracked by Wall St. Rank hold KPRX as of Q3 2025.

  • AIGH Capital Management reported no remaining Kiora Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • AIGH Capital Management sold 216,345 Kiora Pharmaceuticals shares in Q3 2025, an estimated $623K.
  • AIGH Capital Management first reported a position in Kiora Pharmaceuticals in Q1 2024 and held it in 6 quarters.
  • AIGH Capital Management's Kiora Pharmaceuticals position peaked at $1.62M in Q1 2024.
  • 17 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q3 2025.

Based on AIGH Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.